Empresa Ra Pharmaceuticals, Inc.
Acciones
US74933V1089
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Simon Read
CTO | Chief Tech/Sci/R&D Officer | 53 | 04/04/16 |
Chief Tech/Sci/R&D Officer | 47 | 01/07/16 | |
Alonso Ricardo
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/01/10 |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Peter DiRoma
LAW | General Counsel | - | 01/11/18 |
Kerry Black
PRN | Corporate Officer/Principal | - | 01/03/10 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Charl van Zyl
BRD | Director/Board Member | 57 | 02/04/20 |
Director/Board Member | 63 | 02/04/20 | |
Abhinav Kumar
BRD | Director/Board Member | - | 02/04/20 |
Denelle Waynick
BRD | Director/Board Member | 57 | 02/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 47 328 875 | 45 417 827 ( 95,96 %) | 0 | 95,96 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,15 % | 105 mil M | |
-1,08 % | 104 mil M | |
+5,79 % | 22,94 mil M | |
-11,55 % | 22,34 mil M | |
-7,01 % | 19,25 mil M | |
-37,08 % | 17,08 mil M | |
-9,91 % | 16,96 mil M | |
+7,55 % | 14,16 mil M | |
+40,04 % | 12,63 mil M |